HEADER TRANSFERASE/INHIBITOR 03-APR-20 6WF5
TITLE CRYSTAL STRUCTURE OF HUMAN NAA50 IN COMPLEX WITH A TRUNCATED COFACTOR
TITLE 2 DERIVED INHIBITOR (COMPOUND 2)
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: N-ALPHA-ACETYLTRANSFERASE 50;
COMPND 3 CHAIN: A, B;
COMPND 4 SYNONYM: HNAA50P,N-ACETYLTRANSFERASE 13,N-ACETYLTRANSFERASE 5,HNAT5,
COMPND 5 N-ACETYLTRANSFERASE SAN HOMOLOG,HSAN,N-EPSILON-ACETYLTRANSFERASE 50,
COMPND 6 NATE CATALYTIC SUBUNIT, NAA50;
COMPND 7 EC: 2.3.1.258,2.3.1.-;
COMPND 8 ENGINEERED: YES;
COMPND 9 MOL_ID: 2;
COMPND 10 MOLECULE: ACE-MET-LEU-GLY-PRO-NH2;
COMPND 11 CHAIN: C, D;
COMPND 12 ENGINEERED: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 3 ORGANISM_COMMON: HUMAN;
SOURCE 4 ORGANISM_TAXID: 9606;
SOURCE 5 GENE: NAA50, MAK3, NAT13, NAT5;
SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3);
SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008;
SOURCE 8 MOL_ID: 2;
SOURCE 9 SYNTHETIC: YES;
SOURCE 10 ORGANISM_SCIENTIFIC: SYNTHETIC CONSTRUCT;
SOURCE 11 ORGANISM_TAXID: 32630
KEYWDS N-ALPHA-ACETYLTRANSFERASE 50, INHIBITOR COMPLEX, TRANSFERASE,
KEYWDS 2 TRANSFERASE-INHIBITOR COMPLEX
EXPDTA X-RAY DIFFRACTION
AUTHOR S.E.GREASLEY,J.FENG,Y.-L.DENG,A.E.STEWART
REVDAT 3 23-OCT-24 6WF5 1 REMARK
REVDAT 2 18-OCT-23 6WF5 1 REMARK
REVDAT 1 01-JUL-20 6WF5 0
JRNL AUTH P.P.KUNG,P.BINGHAM,B.J.BURKE,Q.CHEN,X.CHENG,Y.L.DENG,D.DOU,
JRNL AUTH 2 J.FENG,G.M.GALLEGO,M.R.GEHRING,S.K.GRANT,S.GREASLEY,
JRNL AUTH 3 A.R.HARRIS,K.A.MAEGLEY,J.MEIER,X.MENG,J.L.MONTANO,
JRNL AUTH 4 B.A.MORGAN,B.S.NAUGHTON,P.B.PALDE,T.A.PAUL,P.RICHARDSON,
JRNL AUTH 5 S.SAKATA,A.SHAGINIAN,W.K.SONNENBURG,C.SUBRAMANYAM,
JRNL AUTH 6 S.TIMOFEEVSKI,J.WAN,W.YAN,A.E.STEWART
JRNL TITL CHARACTERIZATION OF SPECIFICN-ALPHA-ACETYLTRANSFERASE 50
JRNL TITL 2 (NAA50) INHIBITORS IDENTIFIED USING A DNA ENCODED LIBRARY.
JRNL REF ACS MED.CHEM.LETT. V. 11 1175 2020
JRNL REFN ISSN 1948-5875
JRNL PMID 32550998
JRNL DOI 10.1021/ACSMEDCHEMLETT.0C00029
REMARK 2
REMARK 2 RESOLUTION. 2.04 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : BUSTER 2.11.7
REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER,
REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN,
REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.04
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.52
REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000
REMARK 3 COMPLETENESS FOR RANGE (%) : 98.6
REMARK 3 NUMBER OF REFLECTIONS : 21219
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT
REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM
REMARK 3 R VALUE (WORKING + TEST SET) : 0.224
REMARK 3 R VALUE (WORKING SET) : 0.222
REMARK 3 FREE R VALUE : 0.274
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.820
REMARK 3 FREE R VALUE TEST SET COUNT : 1023
REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL
REMARK 3
REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN.
REMARK 3 TOTAL NUMBER OF BINS USED : 11
REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.04
REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.14
REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 97.55
REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2761
REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2470
REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2619
REMARK 3 BIN R VALUE (WORKING SET) : 0.2450
REMARK 3 BIN FREE R VALUE : 0.2920
REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.14
REMARK 3 BIN FREE R VALUE TEST SET COUNT : 142
REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.000
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 2683
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 34
REMARK 3 SOLVENT ATOMS : 98
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : NULL
REMARK 3 MEAN B VALUE (OVERALL, A**2) : 35.30
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : -16.70480
REMARK 3 B22 (A**2) : 5.54960
REMARK 3 B33 (A**2) : 11.15520
REMARK 3 B12 (A**2) : 0.00000
REMARK 3 B13 (A**2) : -6.55800
REMARK 3 B23 (A**2) : 0.00000
REMARK 3
REMARK 3 ESTIMATED COORDINATE ERROR.
REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.330
REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.237
REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.201
REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.241
REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.204
REMARK 3
REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797
REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601
REMARK 3
REMARK 3 CORRELATION COEFFICIENTS.
REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.879
REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.846
REMARK 3
REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15
REMARK 3 TERM COUNT WEIGHT FUNCTION.
REMARK 3 BOND LENGTHS : 2766 ; 2.000 ; HARMONIC
REMARK 3 BOND ANGLES : 3730 ; 2.000 ; HARMONIC
REMARK 3 TORSION ANGLES : 960 ; 2.000 ; SINUSOIDAL
REMARK 3 TRIGONAL CARBON PLANES : 76 ; 2.000 ; HARMONIC
REMARK 3 GENERAL PLANES : 392 ; 5.000 ; HARMONIC
REMARK 3 ISOTROPIC THERMAL FACTORS : 2766 ; 20.000 ; HARMONIC
REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL
REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL
REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL
REMARK 3 CHIRAL IMPROPER TORSION : 345 ; 5.000 ; SEMIHARMONIC
REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL
REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL
REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL
REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL
REMARK 3 IDEAL-DIST CONTACT TERM : 3152 ; 4.000 ; SEMIHARMONIC
REMARK 3
REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES.
REMARK 3 BOND LENGTHS (A) : 0.010
REMARK 3 BOND ANGLES (DEGREES) : 1.13
REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.97
REMARK 3 OTHER TORSION ANGLES (DEGREES) : 19.13
REMARK 3
REMARK 3 TLS DETAILS
REMARK 3 NUMBER OF TLS GROUPS : NULL
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4
REMARK 4 6WF5 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 15-APR-20.
REMARK 100 THE DEPOSITION ID IS D_1000248125.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 20-APR-17
REMARK 200 TEMPERATURE (KELVIN) : 93
REMARK 200 PH : NULL
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : Y
REMARK 200 RADIATION SOURCE : APS
REMARK 200 BEAMLINE : 17-ID
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 1.0
REMARK 200 MONOCHROMATOR : SI(111)
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : PIXEL
REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 S 6M
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS
REMARK 200 DATA SCALING SOFTWARE : AUTOPROC
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 21247
REMARK 200 RESOLUTION RANGE HIGH (A) : 2.040
REMARK 200 RESOLUTION RANGE LOW (A) : 63.590
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 98.8
REMARK 200 DATA REDUNDANCY : 3.300
REMARK 200 R MERGE (I) : 0.12600
REMARK 200 R SYM (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 7.9000
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.04
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.15
REMARK 200 COMPLETENESS FOR SHELL (%) : 98.6
REMARK 200 DATA REDUNDANCY IN SHELL : 3.30
REMARK 200 R MERGE FOR SHELL (I) : 0.72300
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS
REMARK 200 SOFTWARE USED: BUSTER
REMARK 200 STARTING MODEL: 6WF3
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 43.20
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.17
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: CO-CRYSTALLIZATION: NAA50 APO PROTEIN
REMARK 280 (14.3 MG/ML) WAS INCUBATED WITH COMPOUND 2 IN A 1:3 MOLAR RATIO
REMARK 280 ON ICE FOR 60 MIN. RESERVOIR SOLUTION CONTAINING 0.2 M AMMONIUM
REMARK 280 SULFATE AND 30% (W/V) PEG 3K/4K WAS MIXED 1:1 WITH PROTEIN:
REMARK 280 LIGAND COMPLEX, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE
REMARK 280 286.15K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X,Y+1/2,-Z
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 26.16950
REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1, 2
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 TOTAL BURIED SURFACE AREA: 1770 ANGSTROM**2
REMARK 350 SURFACE AREA OF THE COMPLEX: 9950 ANGSTROM**2
REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -9.0 KCAL/MOL
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 350
REMARK 350 BIOMOLECULE: 2
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 TOTAL BURIED SURFACE AREA: 1780 ANGSTROM**2
REMARK 350 SURFACE AREA OF THE COMPLEX: 9430 ANGSTROM**2
REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -9.0 KCAL/MOL
REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, D
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 GLY A -1
REMARK 465 SER A 0
REMARK 465 MET A 1
REMARK 465 LYS A 2
REMARK 465 GLY A 3
REMARK 465 SER A 4
REMARK 465 GLY B -1
REMARK 465 SER B 0
REMARK 465 MET B 1
REMARK 465 LYS B 2
REMARK 465 GLY B 3
REMARK 465 SER B 4
REMARK 465 SER B 158
REMARK 465 GLY B 159
REMARK 465 GLN B 160
REMARK 465 ASN B 161
REMARK 465 ALA B 162
REMARK 465 ASP B 163
REMARK 470
REMARK 470 MISSING ATOM
REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER;
REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER;
REMARK 470 I=INSERTION CODE):
REMARK 470 M RES CSSEQI ATOMS
REMARK 470 ARG B 141 CD NE CZ NH1 NH2
REMARK 470 LYS B 155 CG CD CE NZ
REMARK 470 GLN B 165 CG CD OE1 NE2
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 ARG A 141 -36.84 67.92
REMARK 500 LYS B 140 -79.98 -54.48
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS
REMARK 500
REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH
REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED
REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND
REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES.
REMARK 500 MODEL OMEGA
REMARK 500 GLY D 4 PRO D 5 -33.63
REMARK 500
REMARK 500 REMARK: NULL
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide ACE C 1 and MET C 2
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC2
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide PRO C 5 and NH2 C 6
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC3
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residues U44 C 101 and ACE C 1
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC4
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide ACE G 1 and MET G 2
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC5
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide PRO G 5 and NH2 G 6
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC6
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residues U44 G 101 and ACE G 1
REMARK 900
REMARK 900 RELATED ENTRIES
REMARK 900 RELATED ID: 6WF3 RELATED DB: PDB
DBREF 6WF5 A 1 169 UNP Q9GZZ1 NAA50_HUMAN 1 169
DBREF 6WF5 B 1 169 UNP Q9GZZ1 NAA50_HUMAN 1 169
DBREF 6WF5 C 1 6 PDB 6WF5 6WF5 1 6
DBREF 6WF5 D 1 6 PDB 6WF5 6WF5 1 6
SEQADV 6WF5 GLY A -1 UNP Q9GZZ1 EXPRESSION TAG
SEQADV 6WF5 SER A 0 UNP Q9GZZ1 EXPRESSION TAG
SEQADV 6WF5 GLY B -1 UNP Q9GZZ1 EXPRESSION TAG
SEQADV 6WF5 SER B 0 UNP Q9GZZ1 EXPRESSION TAG
SEQRES 1 A 171 GLY SER MET LYS GLY SER ARG ILE GLU LEU GLY ASP VAL
SEQRES 2 A 171 THR PRO HIS ASN ILE LYS GLN LEU LYS ARG LEU ASN GLN
SEQRES 3 A 171 VAL ILE PHE PRO VAL SER TYR ASN ASP LYS PHE TYR LYS
SEQRES 4 A 171 ASP VAL LEU GLU VAL GLY GLU LEU ALA LYS LEU ALA TYR
SEQRES 5 A 171 PHE ASN ASP ILE ALA VAL GLY ALA VAL CYS CYS ARG VAL
SEQRES 6 A 171 ASP HIS SER GLN ASN GLN LYS ARG LEU TYR ILE MET THR
SEQRES 7 A 171 LEU GLY CYS LEU ALA PRO TYR ARG ARG LEU GLY ILE GLY
SEQRES 8 A 171 THR LYS MET LEU ASN HIS VAL LEU ASN ILE CYS GLU LYS
SEQRES 9 A 171 ASP GLY THR PHE ASP ASN ILE TYR LEU HIS VAL GLN ILE
SEQRES 10 A 171 SER ASN GLU SER ALA ILE ASP PHE TYR ARG LYS PHE GLY
SEQRES 11 A 171 PHE GLU ILE ILE GLU THR LYS LYS ASN TYR TYR LYS ARG
SEQRES 12 A 171 ILE GLU PRO ALA ASP ALA HIS VAL LEU GLN LYS ASN LEU
SEQRES 13 A 171 LYS VAL PRO SER GLY GLN ASN ALA ASP VAL GLN LYS THR
SEQRES 14 A 171 ASP ASN
SEQRES 1 B 171 GLY SER MET LYS GLY SER ARG ILE GLU LEU GLY ASP VAL
SEQRES 2 B 171 THR PRO HIS ASN ILE LYS GLN LEU LYS ARG LEU ASN GLN
SEQRES 3 B 171 VAL ILE PHE PRO VAL SER TYR ASN ASP LYS PHE TYR LYS
SEQRES 4 B 171 ASP VAL LEU GLU VAL GLY GLU LEU ALA LYS LEU ALA TYR
SEQRES 5 B 171 PHE ASN ASP ILE ALA VAL GLY ALA VAL CYS CYS ARG VAL
SEQRES 6 B 171 ASP HIS SER GLN ASN GLN LYS ARG LEU TYR ILE MET THR
SEQRES 7 B 171 LEU GLY CYS LEU ALA PRO TYR ARG ARG LEU GLY ILE GLY
SEQRES 8 B 171 THR LYS MET LEU ASN HIS VAL LEU ASN ILE CYS GLU LYS
SEQRES 9 B 171 ASP GLY THR PHE ASP ASN ILE TYR LEU HIS VAL GLN ILE
SEQRES 10 B 171 SER ASN GLU SER ALA ILE ASP PHE TYR ARG LYS PHE GLY
SEQRES 11 B 171 PHE GLU ILE ILE GLU THR LYS LYS ASN TYR TYR LYS ARG
SEQRES 12 B 171 ILE GLU PRO ALA ASP ALA HIS VAL LEU GLN LYS ASN LEU
SEQRES 13 B 171 LYS VAL PRO SER GLY GLN ASN ALA ASP VAL GLN LYS THR
SEQRES 14 B 171 ASP ASN
SEQRES 1 C 6 ACE MET LEU GLY PRO NH2
SEQRES 1 D 6 ACE MET LEU GLY PRO NH2
HET ACE C 1 3
HET NH2 C 6 1
HET ACE D 1 3
HET NH2 D 6 1
HET U44 C 101 17
HET U44 D 101 17
HETNAM ACE ACETYL GROUP
HETNAM NH2 AMINO GROUP
HETNAM U44 (2R)-2-HYDROXY-3,3-DIMETHYL-N-{3-OXO-3-[(2-
HETNAM 2 U44 SULFANYLETHYL)AMINO]PROPYL}BUTANAMIDE
FORMUL 3 ACE 2(C2 H4 O)
FORMUL 3 NH2 2(H2 N)
FORMUL 5 U44 2(C11 H22 N2 O3 S)
FORMUL 7 HOH *98(H2 O)
HELIX 1 AA1 ASN A 15 PHE A 27 1 13
HELIX 2 AA2 ASN A 32 LEU A 40 1 9
HELIX 3 AA3 GLU A 41 GLU A 44 5 4
HELIX 4 AA4 HIS A 65 GLN A 69 5 5
HELIX 5 AA5 ALA A 81 ARG A 84 5 4
HELIX 6 AA6 GLY A 87 GLY A 104 1 18
HELIX 7 AA7 ASN A 117 LYS A 126 1 10
HELIX 8 AA8 ASN A 161 GLN A 165 5 5
HELIX 9 AA9 ASN B 15 PHE B 27 1 13
HELIX 10 AB1 ASN B 32 LEU B 40 1 9
HELIX 11 AB2 VAL B 42 GLU B 44 5 3
HELIX 12 AB3 HIS B 65 GLN B 69 5 5
HELIX 13 AB4 ALA B 81 ARG B 84 5 4
HELIX 14 AB5 GLY B 87 GLY B 104 1 18
HELIX 15 AB6 ASN B 117 LYS B 126 1 10
SHEET 1 AA1 7 ILE A 6 ASP A 10 0
SHEET 2 AA1 7 ALA A 46 PHE A 51 -1 O LEU A 48 N GLY A 9
SHEET 3 AA1 7 ILE A 54 ASP A 64 -1 O GLY A 57 N ALA A 49
SHEET 4 AA1 7 ARG A 71 CYS A 79 -1 O ARG A 71 N ASP A 64
SHEET 5 AA1 7 ASN A 108 GLN A 114 1 O TYR A 110 N LEU A 72
SHEET 6 AA1 7 ALA A 147 ASN A 153 -1 O HIS A 148 N VAL A 113
SHEET 7 AA1 7 GLU A 130 LYS A 135 -1 N LYS A 135 O ALA A 147
SHEET 1 AA2 7 ILE B 6 ASP B 10 0
SHEET 2 AA2 7 ALA B 46 PHE B 51 -1 O LEU B 48 N GLY B 9
SHEET 3 AA2 7 ILE B 54 ASP B 64 -1 O GLY B 57 N ALA B 49
SHEET 4 AA2 7 ARG B 71 CYS B 79 -1 O ARG B 71 N ASP B 64
SHEET 5 AA2 7 ASN B 108 GLN B 114 1 O TYR B 110 N ILE B 74
SHEET 6 AA2 7 ALA B 147 ASN B 153 -1 O HIS B 148 N VAL B 113
SHEET 7 AA2 7 GLU B 130 LYS B 135 -1 N GLU B 133 O VAL B 149
LINK C ACE C 1 N MET C 2 1555 1555 1.38
LINK CH3 ACE C 1 S2 U44 C 101 1555 1555 1.81
LINK C PRO C 5 N NH2 C 6 1555 1555 1.38
LINK C ACE D 1 N MET D 2 1555 1555 1.38
LINK CH3 ACE D 1 S2 U44 D 101 1555 1555 1.81
LINK C PRO D 5 N NH2 D 6 1555 1555 1.38
CISPEP 1 GLU A 143 PRO A 144 0 0.72
CISPEP 2 GLU B 143 PRO B 144 0 -0.96
CISPEP 3 GLY C 4 PRO C 5 0 -25.06
SITE 1 AC1 14 PHE A 27 PRO A 28 TYR A 31 MET A 75
SITE 2 AC1 14 THR A 76 LEU A 77 LEU A 111 HIS A 112
SITE 3 AC1 14 GLN A 114 TYR A 139 HOH A 207 LEU C 3
SITE 4 AC1 14 GLY C 4 U44 C 101
SITE 1 AC2 5 VAL A 29 TYR A 138 LYS A 140 ASP A 163
SITE 2 AC2 5 GLY C 4
SITE 1 AC3 15 PHE A 27 MET A 75 THR A 76 LEU A 77
SITE 2 AC3 15 GLY A 78 CYS A 79 ARG A 84 LEU A 111
SITE 3 AC3 15 HIS A 112 ASN A 117 PHE A 123 TYR A 124
SITE 4 AC3 15 HOH A 231 MET C 2 HOH C 201
SITE 1 AC4 12 PHE B 27 PRO B 28 TYR B 31 MET B 75
SITE 2 AC4 12 THR B 76 LEU B 77 LEU B 111 HIS B 112
SITE 3 AC4 12 TYR B 139 LEU D 3 GLY D 4 U44 D 101
SITE 1 AC5 2 TYR B 138 GLY D 4
SITE 1 AC6 14 PHE B 27 MET B 75 THR B 76 LEU B 77
SITE 2 AC6 14 GLY B 78 CYS B 79 ARG B 84 LEU B 111
SITE 3 AC6 14 HIS B 112 ASN B 117 SER B 119 PHE B 123
SITE 4 AC6 14 TYR B 124 MET D 2
CRYST1 50.937 52.339 64.123 90.00 97.38 90.00 P 1 21 1 4
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.019632 0.000000 0.002543 0.00000
SCALE2 0.000000 0.019106 0.000000 0.00000
SCALE3 0.000000 0.000000 0.015725 0.00000